Published in Proc Natl Acad Sci U S A on May 04, 2010
Derivation of novel human ground state naive pluripotent stem cells. Nature (2013) 5.90
The transcriptional and epigenomic foundations of ground state pluripotency. Cell (2012) 5.87
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94
Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell (2012) 2.93
Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet (2011) 2.81
Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell (2014) 2.68
Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell (2014) 2.60
Female human iPSCs retain an inactive X chromosome. Cell Stem Cell (2010) 2.59
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
The transcriptional and signalling networks of pluripotency. Nat Cell Biol (2011) 2.54
Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature (2013) 2.47
Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell (2012) 2.42
Generation of chimeric rhesus monkeys. Cell (2012) 2.41
esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat Cell Biol (2011) 2.29
Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci (2011) 2.09
Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A (2014) 2.04
Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A (2011) 1.97
Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol (2012) 1.93
Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol (2010) 1.86
Efficient feeder-free episomal reprogramming with small molecules. PLoS One (2011) 1.79
Blimp1 expression predicts embryonic stem cell development in vitro. Curr Biol (2011) 1.76
Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73
Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol (2011) 1.69
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A (2011) 1.63
Hallmarks of pluripotency. Nature (2015) 1.60
Epiblast stem cell-based system reveals reprogramming synergy of germline factors. Cell Stem Cell (2012) 1.54
Enhancers as information integration hubs in development: lessons from genomics. Trends Genet (2012) 1.52
A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells. J Cell Sci (2011) 1.50
Human Naive Pluripotent Stem Cells Model X Chromosome Dampening and X Inactivation. Cell Stem Cell (2016) 1.49
Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells. Nature (2014) 1.47
Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J (2013) 1.46
Human hypoblast formation is not dependent on FGF signalling. Dev Biol (2011) 1.46
Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J (2011) 1.41
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41
Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. Dev Cell (2012) 1.37
JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat Commun (2012) 1.37
Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res (2010) 1.32
Defining the three cell lineages of the human blastocyst by single-cell RNA-seq. Development (2015) 1.32
Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog (2012) 1.29
Generation of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development. Stem Cells Dev (2012) 1.27
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci (2013) 1.26
Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell (2013) 1.25
New perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev (2012) 1.23
The roles of FGF and MAP kinase signaling in the segregation of the epiblast and hypoblast cell lineages in bovine and human embryos. Development (2012) 1.23
Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell (2012) 1.23
Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun (2013) 1.23
Replication timing: a fingerprint for cell identity and pluripotency. PLoS Comput Biol (2011) 1.21
The liberation of embryonic stem cells. PLoS Genet (2011) 1.20
Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports (2014) 1.18
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep (2014) 1.16
The transcriptional regulation of pluripotency. Cell Res (2012) 1.15
X-inactivation and X-reactivation: epigenetic hallmarks of mammalian reproduction and pluripotent stem cells. Hum Genet (2011) 1.14
Accessing naïve human pluripotency. Curr Opin Genet Dev (2012) 1.13
Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci (2012) 1.12
Auxetic nuclei in embryonic stem cells exiting pluripotency. Nat Mater (2014) 1.11
Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc Natl Acad Sci U S A (2010) 1.10
Attenuation of extrinsic signaling reveals the importance of matrix remodeling on maintenance of embryonic stem cell self-renewal. Proc Natl Acad Sci U S A (2012) 1.08
Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol (2016) 1.07
Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. J Cell Physiol (2011) 1.06
Genomic approaches to deconstruct pluripotency. Annu Rev Genomics Hum Genet (2011) 1.06
A genome-wide RNAi screen reveals MAP kinase phosphatases as key ERK pathway regulators during embryonic stem cell differentiation. PLoS Genet (2012) 1.05
Leukemia inhibitory factor (LIF)-dependent, pluripotent stem cells established from inner cell mass of porcine embryos. J Biol Chem (2011) 1.05
The Oct4 protein: more than a magic stemness marker. Am J Stem Cells (2014) 1.05
Model systems for studying trophoblast differentiation from human pluripotent stem cells. Cell Tissue Res (2012) 1.05
ZFX controls the self-renewal of human embryonic stem cells. PLoS One (2012) 1.03
Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cells Dev (2011) 1.03
Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin. Hum Mol Genet (2011) 1.02
TGF-β family signaling in stem cells. Biochim Biophys Acta (2012) 1.01
Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One (2011) 1.01
Developing defined culture systems for human pluripotent stem cells. Regen Med (2011) 1.01
Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta (2012) 1.00
Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig. PLoS One (2013) 0.99
Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. Nat Commun (2015) 0.99
Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci (2012) 0.98
Signaling networks in human pluripotent stem cells. Curr Opin Cell Biol (2012) 0.97
X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry (2012) 0.97
Switching on pluripotency: a perspective on the biological requirement of Nanog. Philos Trans R Soc Lond B Biol Sci (2011) 0.97
Lineage-specific function of the noncoding Tsix RNA for Xist repression and Xi reactivation in mice. Genes Dev (2011) 0.96
Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Development (2011) 0.96
X-chromosome epigenetic reprogramming in pluripotent stem cells via noncoding genes. Semin Cell Dev Biol (2011) 0.96
Role of the epithelial-mesenchymal transition and its effects on embryonic stem cells. Exp Mol Med (2014) 0.96
Chemical approaches to studying stem cell biology. Cell Res (2012) 0.95
Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells. Stem Cells Dev (2014) 0.95
Non-colony type monolayer culture of human embryonic stem cells. Stem Cell Res (2012) 0.94
Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application. Blood Res (2014) 0.94
Concise review: Pluripotency and the transcriptional inactivation of the female Mammalian X chromosome. Stem Cells (2012) 0.94
MicroRNA profiling of rhesus macaque embryonic stem cells. BMC Genomics (2011) 0.94
Regulatory non-coding RNAs in pluripotent stem cells. Int J Mol Sci (2013) 0.93
Germ cell specification and pluripotency in mammals: a perspective from early embryogenesis. Reprod Med Biol (2014) 0.93
The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states. Curr Opin Genet Dev (2013) 0.93
Induced pluripotent stem cells derived from rabbits exhibit some characteristics of naïve pluripotency. Biol Open (2013) 0.93
The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells. Proc Natl Acad Sci U S A (2014) 0.92
TBX3 promotes human embryonic stem cell proliferation and neuroepithelial differentiation in a differentiation stage-dependent manner. Stem Cells (2012) 0.92
Generation of virus-free induced pluripotent stem cell clones on a synthetic matrix via a single cell subcloning in the naïve state. PLoS One (2012) 0.92
Mechanistic insights into reprogramming to induced pluripotency. J Cell Physiol (2011) 0.92
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
The ground state of embryonic stem cell self-renewal. Nature (2008) 19.44
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell (2008) 14.17
New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature (2007) 13.54
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature (2007) 11.72
Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics (2006) 10.83
Direct cell reprogramming is a stochastic process amenable to acceleration. Nature (2009) 8.71
Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell (2008) 7.79
Feeder-independent culture of human embryonic stem cells. Nat Methods (2006) 7.61
Naive and primed pluripotent states. Cell Stem Cell (2009) 7.15
A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol (2008) 6.90
Capture of authentic embryonic stem cells from rat blastocysts. Cell (2008) 6.60
Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol (2008) 6.19
Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell (2004) 6.08
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell (2008) 5.83
Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development (2009) 5.49
Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A (1998) 4.92
NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell (2008) 4.88
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell (2009) 4.64
Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature (2003) 4.56
Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell (2010) 4.32
Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development (2009) 4.25
Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell (2009) 3.92
Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature (2009) 3.43
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell (2009) 3.27
X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 3.25
Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. Nature (2009) 2.79
Stem cells and early lineage development. Cell (2008) 2.77
Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell (2010) 2.73
X-Chromosome inactivation in cloned mouse embryos. Science (2000) 2.59
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development (2006) 2.27
Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med (2009) 2.26
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. Mamm Genome (2001) 1.89
The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal (2005) 1.67
Self-renewing epiblast stem cells exhibit continual delineation of germ cells with epigenetic reprogramming in vitro. Development (2009) 1.66
Many ways to pluripotency. Nat Biotechnol (2007) 1.03
Male germline and embryonic stem cell lines from NOD mice: efficient derivation of GS cells from a nonpermissive strain for ES cell derivation. Biol Reprod (2009) 1.02
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
Control of developmental regulators by Polycomb in human embryonic stem cells. Cell (2006) 28.21
Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38
Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 15.13
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell (2008) 12.29
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol (2011) 11.76
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature (2011) 11.31
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell (2008) 10.68
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84
Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A (2004) 9.33
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet (2007) 9.25
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04
Induction of tumors in mice by genomic hypomethylation. Science (2003) 8.86
Direct cell reprogramming is a stochastic process amenable to acceleration. Nature (2009) 8.71
Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res (2005) 8.69
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell (2007) 8.46
YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol (2007) 8.11
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol (2008) 7.91
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
HDAC2 negatively regulates memory formation and synaptic plasticity. Nature (2009) 6.96
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56
Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02
Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat Genet (2002) 5.51
Notch signalling regulates stem cell numbers in vitro and in vivo. Nature (2006) 5.49
Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40
Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron (2006) 4.74
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells (2008) 4.67
Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell (2010) 4.59
Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell (2002) 4.56
Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell (2011) 4.52
Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2005) 4.52
Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A (2008) 4.48
Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell (2008) 4.43
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol (2008) 4.41
Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell (2010) 4.32
Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature (2002) 4.16
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem (2005) 3.97
Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res (2010) 3.94
Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell (2009) 3.92
H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell (2008) 3.90
DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet (2009) 3.73
Nuclear reprogramming and pluripotency. Nature (2006) 3.68
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev Cell (2013) 3.31
Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell (2011) 3.31